| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-11 17:50:08 UTC |
|---|
| Update Date | 2022-03-07 02:53:22 UTC |
|---|
| HMDB ID | HMDB0032499 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Pyrrolidino-[1,2E]-4H-2,4-dimethyl-1,3,5-dithiazine |
|---|
| Description | Pyrrolidino-[1,2E]-4H-2,4-dimethyl-1,3,5-dithiazine, also known as pyrrolidino[1,2-e]-4H-1,3,5-dithiazine, 2,4-dimethyl, belongs to the class of organic compounds known as 1,3,5-dithiazinanes. These are cyclic compounds that contain a dithiazinane ring, which is a saturated heterocycle that consisting of one nitrogen atom, two sulfur atoms at the 1-,3-, and 5- position, respectively. Based on a literature review a significant number of articles have been published on Pyrrolidino-[1,2E]-4H-2,4-dimethyl-1,3,5-dithiazine. |
|---|
| Structure | InChI=1S/C8H15NS2/c1-6-9-5-3-4-8(9)11-7(2)10-6/h6-8H,3-5H2,1-2H3 |
|---|
| Synonyms | | Value | Source |
|---|
| Pyrrolidino[1,2-e]-4H-1,3,5-dithiazine, 2,4-dimethyl | HMDB | | Pyrrolidino[1,2-e]-4H-2,4-dimethyl-1,3,5-dithiazine | HMDB |
|
|---|
| Chemical Formula | C8H15NS2 |
|---|
| Average Molecular Weight | 189.341 |
|---|
| Monoisotopic Molecular Weight | 189.064590865 |
|---|
| IUPAC Name | 2,4-dimethyl-hexahydropyrrolo[2,1-d][1,3,5]dithiazine |
|---|
| Traditional Name | 2,4-dimethyl-hexahydropyrrolo[2,1-d][1,3,5]dithiazine |
|---|
| CAS Registry Number | 116505-60-3 |
|---|
| SMILES | CC1SC2CCCN2C(C)S1 |
|---|
| InChI Identifier | InChI=1S/C8H15NS2/c1-6-9-5-3-4-8(9)11-7(2)10-6/h6-8H,3-5H2,1-2H3 |
|---|
| InChI Key | OJEOXDLLIADRBL-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as 1,3,5-dithiazinanes. These are cyclic compounds that contain a dithiazinane ring, which is a saturated heterocycle that consisting of one nitrogen atom, two sulfur atoms at the 1-,3-, and 5- position, respectively. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Azacyclic compounds |
|---|
| Sub Class | Dithiazinanes |
|---|
| Direct Parent | 1,3,5-dithiazinanes |
|---|
| Alternative Parents | |
|---|
| Substituents | - 1,3,5-dithiazinane
- N-alkylpyrrolidine
- Pyrrolidine
- Thioacetal
- Dialkylthioether
- Hemithioaminal
- Thioether
- Organic nitrogen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Organonitrogen compound
- Aliphatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aliphatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | |
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | | Show more...
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. | 2.95 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 14.5592 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 3.08 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 40.1 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1689.6 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 455.7 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 167.4 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 263.4 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 131.0 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 516.4 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 418.0 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 82.8 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 993.1 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 373.0 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1266.1 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 335.8 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 328.0 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 396.4 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 393.2 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 44.9 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatized| Metabolite | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Pyrrolidino-[1,2E]-4H-2,4-dimethyl-1,3,5-dithiazine | CC1SC2CCCN2C(C)S1 | 1977.5 | Standard polar | 33892256 | | Pyrrolidino-[1,2E]-4H-2,4-dimethyl-1,3,5-dithiazine | CC1SC2CCCN2C(C)S1 | 1445.7 | Standard non polar | 33892256 | | Pyrrolidino-[1,2E]-4H-2,4-dimethyl-1,3,5-dithiazine | CC1SC2CCCN2C(C)S1 | 1530.7 | Semi standard non polar | 33892256 |
| Show more...
|---|